These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27721041)

  • 1. Very fast dissolving acid carboxymethylcellulose-rifampicin matrix: Development and solid-state characterization.
    Luciani-Giacobbe LC; Ramírez-Rigo MV; Garro-Linck Y; Monti GA; Manzo RH; Olivera ME
    Eur J Pharm Sci; 2017 Jan; 96():398-410. PubMed ID: 27721041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-state characterization of rifampicin samples and its biopharmaceutic relevance.
    Agrawal S; Ashokraj Y; Bharatam PV; Pillai O; Panchagnula R
    Eur J Pharm Sci; 2004 Jun; 22(2-3):127-44. PubMed ID: 15158898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tuberculosis site-specific oral delivery system that enhances rifampicin bioavailability in a fixed-dose combination with isoniazid.
    Luciani-Giacobbe LC; Lorenzutti AM; Litterio NJ; Ramírez-Rigo MV; Olivera ME
    Drug Deliv Transl Res; 2021 Jun; 11(3):894-908. PubMed ID: 32901368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change.
    Oh DH; Park YJ; Kang JH; Yong CS; Choi HG
    Drug Deliv; 2011 Jan; 18(1):46-53. PubMed ID: 20726805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and superficial transformations on mini-matrices made of interpolymer complexes of chitosan and carboxymethylcellulose during in vitro clarithromycin release.
    Gómez-Burgaz M; Torrado G; Torrado S
    Eur J Pharm Biopharm; 2009 Sep; 73(1):130-9. PubMed ID: 19406235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-state characterization and dissolution properties of Fluvastatin sodium salt hydrates.
    Borgmann SH; Bernardi LS; Rauber GS; Oliveira PR; Campos CE; Monti G; Cuffini SL; Cardoso SG
    Pharm Dev Technol; 2013; 18(2):525-34. PubMed ID: 23033850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Situ Monitoring and Modeling of the Solution-Mediated Polymorphic Transformation of Rifampicin: From Form II to Form I.
    Guo N; Hou B; Wang N; Xiao Y; Huang J; Guo Y; Zong S; Hao H
    J Pharm Sci; 2018 Jan; 107(1):344-352. PubMed ID: 29031974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amorphous content on dissolution characteristics of rifampicin.
    Panchagnula R; Bhardwaj V
    Drug Dev Ind Pharm; 2008 Jun; 34(6):642-9. PubMed ID: 18568915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids.
    Maher EM; Ali AM; Salem HF; Abdelrahman AA
    Drug Deliv; 2016 Oct; 23(8):3088-3100. PubMed ID: 26960680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the solubility and dissolution properties of several new rifampicin polymorphs, solvates, and hydrates.
    Henwood SQ; Liebenberg W; Tiedt LR; Lötter AP; de Villiers MM
    Drug Dev Ind Pharm; 2001 Nov; 27(10):1017-30. PubMed ID: 11794804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions.
    Medarević DP; Kachrimanis K; Mitrić M; Djuriš J; Djurić Z; Ibrić S
    Pharm Dev Technol; 2016; 21(3):268-76. PubMed ID: 25582577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin nanocrystals: Towards an innovative approach to treat tuberculosis.
    Melo KJC; Henostroza MAB; Löbenberg R; Bou-Chacra NA
    Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110895. PubMed ID: 32409052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety.
    Singh H; Jindal S; Singh M; Sharma G; Kaur IP
    Int J Pharm; 2015 May; 485(1-2):138-51. PubMed ID: 25769294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization of tacrolimus-loaded solid dispersion with sodium carboxylmethyl cellulose and sodium lauryl sulfate.
    Park YJ; Ryu DS; Li DX; Quan QZ; Oh DH; Kim JO; Seo YG; Lee YI; Yong CS; Woo JS; Choi HG
    Arch Pharm Res; 2009 Jun; 32(6):893-8. PubMed ID: 19557367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel rifampicin-phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation.
    Singh C; Bhatt TD; Gill MS; Suresh S
    Int J Pharm; 2014 Jan; 460(1-2):220-7. PubMed ID: 24188983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
    Thongnopkoon T; Puttipipatkhachorn S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swellable drug-polyelectrolyte matrices of drug-carboxymethylcellulose complexes. Characterization and delivery properties.
    Rigo MV; Allemandi DA; Manzo RH
    Drug Deliv; 2009 Feb; 16(2):108-15. PubMed ID: 19267302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.